ArticlePeerJ2026
Psychosocial burden and quality of life impairment in adults with vitiligo: a cross-sectional assessment.
Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vitiligo, a chronic autoimmune depigmenting disorder, substantially affects patients' psychosocial well-being despite its benign physical course. Limited evidence from Saudi Arabia explores the quality-of-life (QoL) impact of vitiligo and its clinical correlates. Objective: To assess QoL impairment among adults with vitiligo and to determine the relationship between disease characteristics and Dermatology Life Quality Index (DLQI) scores. Methods: A cross-sectional, questionnaire-based study was conducted among 121 adults attending a tertiary dermatology center in Saudi Arabia. Data on sociodemographic and clinical variables were collected, and QoL was evaluated using the validated DLQI instrument (Arabic/English). Statistical analyses included descriptive measures, χ Results: Higher DLQI scores were significantly associated with greater body-surface-area involvement, facial + body distribution, and bilateral lesions. Emotional distress, clothing limitations, and restricted social and leisure activities were the most affected domains. Conclusion: Vitiligo markedly impairs QoL, particularly when lesions are visible and extensive. Incorporating routine DLQI screening and psychosocial support into dermatologic practice may improve holistic patient management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.